a cyclical issue with a great story backed up by solid funding
and experts across sectors
it is a survivor
and it rewards early speculators
even strong hands who can average down before the facts news and disclosures
whatever the TREND is
this stock is a facility for heavy hitters to bankroll
and make a windfall for those who got VOLUME at cost of HANDLER
Strategy: the usual Cost Average
Tactic: Buy High Price go Up
dna: DiGiPLUS ACEN DiTO
and experts across sectors
it is a survivor
and it rewards early speculators
even strong hands who can average down before the facts news and disclosures
whatever the TREND is
this stock is a facility for heavy hitters to bankroll
and make a windfall for those who got VOLUME at cost of HANDLER
Strategy: the usual Cost Average
Tactic: Buy High Price go Up
dna: DiGiPLUS ACEN DiTO
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.